Bibliometric analysis on infective endocarditis
Análisis bibliométrico sobre endocarditis infecciosa
Uğur Küçük, Sevil Alkan, Cemile Uyar
Abstract
Introduction: Although infective endocarditis (IE) is rare disease, this disease has importance due to its high morbidity and mortality rates. The exact incidence is not known as it is not a reportable disease. Unlike developed countries, the disease affects the young more than the elderly in developing countries. Most of the time, the diagnosis cannot be made at the first examination and the disease is often overlooked. In order to reduce the mortality and morbidity of this disease, it is important to quickly recognize the disease by following current diagnosis and treatment methods, to identify the causative agent and to treat accordingly. Both the epidemiology and the management of IE are changing due to medical advances. This situation may also be reflected in scientific publications. We aimed to analyze the global researches on IE.
Material and methods: The Scopus database was searched for bibliometric analysis without selecting document type. Data were retrieved for the time period January 1, 1940 and Semptember 26, 2021, containing the keywords " Infective’’ and’’endocarditis " in their title.
Results: 7911 publications were included in the study. The first publication was made in the year 1891. Most of the publications were research articles [n=5784 (73.11%)] and were from the United States of America (USA) [n =1622 (20.50%)]. Japan, France, United Kingdom and Spain were also in the top 5 publishing countries on IE.
Conclusions: Infective endocarditis is still an important reason of mortality, and there are many unanswered questions about the managament and preventation of this disease. This situation reflected the scientific publications. Since this is a global problem, not just some developed countries involved in the IE research, also more countries should be encouraged to participate the studies on IE.
Keywords
Resumen
Introducción: Si bien la endocarditis infecciosa (EI) es una enfermedad rara, esta enfermedad tiene importancia por sus altas tasas de morbilidad y mortalidad. No se conoce la incidencia exacta ya que no es una enfermedad de notificación obligatoria. A diferencia de los países desarrollados, la enfermedad afecta más a los jóvenes que a los ancianos en los países en desarrollo. La mayoría de las veces, el diagnóstico no se puede hacer en el primer examen y la enfermedad a menudo se pasa por alto. Para reducir la mortalidad y morbilidad de esta enfermedad, es importante reconocer rápidamente la enfermedad siguiendo los métodos de diagnóstico y tratamiento actuales, para identificar el agente causal y tratar en consecuencia. Tanto la epidemiología como el manejo de la EI están cambiando debido a los avances médicos. Esta situación también puede verse reflejada en publicaciones científicas. Nuestro objetivo era analizar las investigaciones globales sobre la EI.
Material y métodos: Se buscó en la base de datos Scopus para el análisis bibliométrico sin seleccionar el tipo de documento. Se recuperaron datos para el período de tiempo del 1 de enero de 1940 y el 26 de septiembre de 2021, que contenían las palabras clave "Infeccioso" y "Endocarditis" en su título.
Resultados: Se incluyeron 7911 publicaciones en el estudio. La primera publicación se realizó en el año 1891. La mayoría de las publicaciones fueron artículos de investigación [n = 5784 (73,11%)] y fueron de los Estados Unidos de América (EE.UU.) [n = 1622 (20,50%)]. Japón, Francia, Reino Unido y España también se encontraban entre los 5 principales países editores en la EI.
Conclusiones: La endocarditis infecciosa sigue siendo una causa importante de mortalidad y hay muchas preguntas sin respuesta sobre el manejo y prevención de esta enfermedad. Esta situación reflejó las publicaciones científicas. Dado que este es un problema global, no solo algunos países desarrollados involucrados en la investigación de EI, también se debe alentar a más países a participar en los estudios sobre EI.
Palabras clave
References
1. Cahill TJ, Prendergast BD. Infective endocarditis. Lancet. 2016;387(10021):882-93. doi: 10.1016/S0140-6736(15)00067-7.
2. Doğan A. [Reflections from infective endocarditis guideline by European Society of Cardiology; What will change in our practice?]. Turk Kardiyol Dern Ars. 2015;43(8):673-7. doi: 10.5543/tkda.2015.01384.
3. Şimşek-Yavuz S, Akar AR, Aydoğdu S, Berzeg Deniz D, Demir H, Hazırolan T, et al. Diagnosis, treatment and prevention of infective endocarditis: Turkish consensus report-2019. Turk Kardiyol Dern Ars. 2020;48(2):187-226. doi: 10.5543/tkda.2020.89689.
4. Wang A, Gaca JG, Chu VH. Management Considerations in Infective Endocarditis: A Review. JAMA. 2018;320(1):72-83. doi: 10.1001/jama.2018.7596.
5. Cahill TJ, Baddour LM, Habib G, Hoen B, Salaun E, Pettersson GB, Schäfers HJ, Prendergast BD. Challenges in Infective Endocarditis. J Am Coll Cardiol. 2017;69(3):325-44. doi: 10.1016/j.jacc.2016.10.066.
6. Jain P, Stevenson T, Sheppard A, Rankin K, Compton SM, Preshing W, et al. Antibiotic prophylaxis for infective endocarditis: Knowledge and implementation of American Heart Association Guidelines among dentists and dental hygienists in Alberta, Canada. J Am Dent Assoc. 2015;146(10):743-50. doi: 10.1016/j.adaj.2015.03.021.
7. Adam D. [Antibiotic therapy in infectious endocarditis]. Herz. 1983;8(6):311-9.
8. Shuaib W, Khan MS, Shahid H, Valdes EA, Alweis R. Bibliometric analysis of the top 100 cited cardiovascular articles. Am J Cardiol. 2015;115(7):972-81. doi: 10.1016/j.amjcard.2015.01.029.
9. Chorro FJ, Alonso-Arroyo A, Aleixandre-Benavent R. Trend in Spanish cardiology research and global comparative analysis of major topics. Rev Esp Cardiol (Engl Ed). 2020:S1885-5857(20)30523-5. doi: 10.1016/j.rec.2020.12.001.
10. Zhou H, Tan W, Qiu Z, Song Y, Gao S. A bibliometric analysis in gene research of myocardial infarction from 2001 to 2015. PeerJ. 2018;6:e4354. doi: 10.7717/peerj.4354.
11. Özlü C. Bıblıometrıc Evaluatıon Based On Scopus Database: A Global Analysıs of Publıcatıons on Myelodysplastıc Syndrome and Evaluatıon of
Publıcatıons From Turkey. Biotech Strateg Health Res. 2021;5(2):125-31. doi: 10.34084/bshr.948974.
12. Öntürk H, Dindar Demiray EK, Alkan S. Network analysis of nursing publications in the COVID 19 era. J Clin Med Kaz. 2021;18(4):27-31. doi: 10.23950/jcmk/11037.
13. Dindar Demiray EK, Durğun M, Alkan S. Examination of thesis on Aspergillosis: A Turkish sample. D J Med Sci. 2021;7(2):103-6. doi: 10.5606/fng.btd.2021.25055.
14. Paniagua Cruz A, Zhu KY, Ellimoottil C, Dauw CA, Sarma A, Skolarus TA. Characterizing the Benign Prostatic Hyperplasia Literature: A Bibliometric Analysis. Urology. 2020;136:202-11. doi: 10.1016/j.urology.2019.11.033.
15. Schöffel N, Vitzthum K, Mache S, Groneberg DA, Quarcoo D. The role of endocarditis, myocarditis and pericarditis in qualitative and quantitative data analysis. Int J Environ Res Public Health. 2009;6(12):2919-33. doi: 10.3390/ijerph6122919.
16. Habib G, Badano L, Tribouilloy C, Vilacosta I, Zamorano JL, Galderisi M, et al. Recommendations for the practice of echocardiography in infective endocarditis. Eur J Echocardiogr. 2010;11(2):202-19. doi: 10.1093/ejechocard/jeq004.
17. Fagman E, Perrotta S, Bech-Hanssen O, Flinck A, Lamm C, Olaison L, et al. ECG-gated computed tomography: a new role for patients with suspected aortic prosthetic valve endocarditis. Eur Radiol. 2012;22(11):2407-14. doi: 10.1007/s00330-012-2491-5.
18. Erba PA, Conti U, Lazzeri E, Sollini M, Doria R, De Tommasi SM, et al. Added value of 99mTc-HMPAO-labeled leukocyte SPECT/CT in the characterization and management of patients with infectious endocarditis. J Nucl Med. 2012;53(8):1235-43. doi: 10.2967/jnumed.111.099424.
19. Saby L, Laas O, Habib G, Cammilleri S, Mancini J, Tessonnier L, et al. Positron emission tomography/computed tomography for diagnosis of prosthetic valve endocarditis: increased valvular 18F-fluorodeoxyglucose uptake as a novel major criterion. J Am Coll Cardiol. 2013;61(23):2374-82. doi: 10.1016/j.jacc.2013.01.092.
20. Rouzet F, Chequer R, Benali K, Lepage L, Ghodbane W, Duval X, et al. Respective performance of 18F-FDG PET and radiolabeled leukocyte scintigraphy for the diagnosis of prosthetic valve endocarditis. J Nucl Med. 2014;55(12):1980-5. doi: 10.2967/jnumed.114.141895.
21. Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler VG Jr, Bayer AS, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009;169(5):463-73. doi: 10.1001/archinternmed.2008.603.
22. Cahill TJ, Harrison JL, Jewell P, Onakpoya I, Chambers JB, Dayer M, et al. Antibiotic prophylaxis for infective endocarditis: a systematic review and meta-analysis. Heart. 2017;103(12):937-44. doi: 10.1136/heartjnl-2015-309102.
23. Sy RW, Chawantanpipat C, Richmond DR, Kritharides L. Development and validation of a time-dependent risk model for predicting mortality in infective endocarditis. Eur Heart J. 2011;32(16):2016-26. doi: 10.1093/eurheartj/ehp085.
Submitted date:
10/04/2021
Reviewed date:
10/14/2021
Accepted date:
10/22/2021
Publication date:
10/22/2021
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email